Cognitive Complaints After Breast Cancer Treatments: Examining the Relationship With Neuropsychological Test Performance

Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?

(2012) Patricia A. Ganz et al.   BRAIN BEHAVIOR AND IMMUNITY

Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors

(2012) Shelli Kesler et al.   BRAIN BEHAVIOR AND IMMUNITY

Inflammation and cancer-related fatigue: Mechanisms, contributing factors, and treatment implications

(2012) Julienne E. Bower et al.   BRAIN BEHAVIOR AND IMMUNITY

Alterations in Brain Activation During Working Memory Processing Associated With Breast Cancer and Treatment: A Prospective Functional Magnetic Resonance Imaging Study

(2012) Brenna C. McDonald et al.   JOURNAL OF CLINICAL ONCOLOGY

Meta-Analysis of Cognitive Functioning in Breast Cancer Survivors Previously Treated With Standard-Dose Chemotherapy

(2012) Heather S.L. Jim et al.   JOURNAL OF CLINICAL ONCOLOGY

Reconciling subjective memory complaints with objective memory performance in the menopausal transition

(2012) Miriam T. Weber et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Increased working memory-related brain activity in middle-aged women with cognitive complaints

(2012) Julie A. Dumas et al.   NEUROBIOLOGY OF AGING

Brain vulnerability to chemotherapy toxicities

(2012) Tim A. Ahles   PSYCHO-ONCOLOGY

Prefrontal Cortex and Executive Function Impairments in Primary Breast Cancer

(2011) Shelli R. Kesler   ARCHIVES OF NEUROLOGY

Physical and Psychosocial Recovery in the Year After Primary Treatment of Breast Cancer

(2011) Patricia A. Ganz et al.   JOURNAL OF CLINICAL ONCOLOGY

Inflammation and Behavioral Symptoms After Breast Cancer Treatment: Do Fatigue, Depression, and Sleep Disturbance Share a Common Underlying Mechanism?

(2011) Julienne E. Bower et al.   JOURNAL OF CLINICAL ONCOLOGY

“Doctor, Will the Treatment You Are Recommending Cause Chemobrain?”

(2011) Patricia A. Ganz   JOURNAL OF CLINICAL ONCOLOGY

Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive Functioning

(2011) Sabine Deprez et al.   JOURNAL OF CLINICAL ONCOLOGY

Perimenopause and Cognition

(2011) Gail A. Greendale et al.   OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA

Menopause-associated Symptoms and Cognitive Performance: Results From the Study of Women's Health Across the Nation

(2010) G. A. Greendale et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life

(2010) Pauline M. Maki et al.   BRAIN RESEARCH

Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study

(2010) Brenna C. McDonald et al.   BREAST CANCER RESEARCH AND TREATMENT

Subjective cognitive complaints at menopause associated with declines in performance of verbal memory and attentional processes

(2010) M. Schaafsma et al.   CLIMACTERIC

Subjective cognitive dysfunction in breast cancer patients: a systematic review

(2009) Marleen J.J. Pullens et al.   PSYCHO-ONCOLOGY

Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer

(2008) Andrew H. Miller et al.   JOURNAL OF CLINICAL ONCOLOGY

Neuropsychological Sequelae of Non-Central Nervous System Cancer and Cancer Therapy

(2008) Jeffrey S. Wefel et al.   NEUROPSYCHOLOGY REVIEW

Life-time estrogen exposure and cognitive functioning in later life

(2008) Joanne Ryan et al.   PSYCHONEUROENDOCRINOLOGY